Thalidomide in advanced hepatocellular carcinoma as antiangiogenic treatment approach : a phase l/ll trialPINTER, Matthias; WICHLAS, Martina; SCHMID, Katharina et al.European journal of gastroenterology & hepatology. 2008, Vol 20, Num 10, pp 1012-1019, issn 0954-691X, 8 p.Article

Erlotinib and sorafenib in an orthotopic rat model of hepatocellular carcinomaSIEGHART, Wolfgang; PINTER, Matthias; DAUSER, Bernhard et al.Journal of hepatology. 2012, Vol 57, Num 3, pp 592-599, issn 0168-8278, 8 p.Article

Advanced-Stage Hepatocellular Carcinoma: Transarterlal Chemoembolization versus SorafenibPINTER, Matthias; HUCKE, Florian; PECK-RADOSAVLJEVIC, Markus et al.Radiology. 2012, Vol 263, Num 2, pp 590-599, issn 0033-8419, 10 p.Article

Osteopontin expression predicts overall survival after liver transplantation for hepatocellular carcinoma in patients beyond the Milan criteriaSIEGHART, Wolfgang; XIAOWEI WANG; SCHMID, Katharina et al.Journal of hepatology. 2011, Vol 54, Num 1, pp 89-97, issn 0168-8278, 9 p.Article